Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

• Status: Withdrawn
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to determine the relative effectiveness of buprenorphine/naloxone (Suboxone) pharmacotherapy versus naltrexone pharmacotherapy for treatment retention, relapse prevention and opioid craving reduction among opioid-dependent adolescents and young adults. The investigators hypothesize that naltrexone treatment is as effective as buprenorphine/naloxone for these treatment outcomes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: State University of New York at Buffalo
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone; Naltrexone

Criteria

Inclusion Criteria:

• Clinical Diagnosis of Opiate Dependence

• Successful completion of detoxification

• can answer 9 out of 10 question correctly that tests understanding of the study

Exclusion Criteria:

• unable to pay for medication

• not living with a parent/guardian

• inability of patient and/or parent to give consent

• major co-occurring psychiatric disorder

• existing medical condition that would interfere with the treatment

• use of CNS depressants

• pregnancy